116 related articles for article (PubMed ID: 10813290)
1. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
2. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
De Miguel E; Karalilova R; Macchioni P; Ponte C; Conticini E; Cowley S; Tomelleri A; Monti S; Monjo I; Batalov Z; Klinowski G; Falsetti P; Kane DJ; Campochiaro C; Hočevar A
Ann Rheum Dis; 2024 Feb; 83(3):335-341. PubMed ID: 37932008
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein gene polymorphisms influence susceptibility and outcomes of biopsy-proven giant cell arteritis in Italian patients.
Boiardi L; Farnetti E; Macchioni P; Nicoli D; Croci S; Muratore F; Marvisi C; Ricordi C; Catanoso M; Galli E; Salvarani C
Clin Exp Rheumatol; 2024 Apr; 42(4):803-810. PubMed ID: 37534674
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study.
Barde F; Ascione S; Pacoureau L; Macdonald C; Salliot C; Boutron-Ruault MC; Seror R; Nguyen Y
Semin Arthritis Rheum; 2024 Feb; 64():152298. PubMed ID: 38000317
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica.
De Miguel E; Macchioni P; Conticini E; Campochiaro C; Karalilova R; Monti S; Ponte C; Klinowski G; Monjo-Henry I; Falsetti P; Batalov Z; Tomelleri A; Hocevar A
Rheumatology (Oxford); 2024 Jan; 63(1):158-164. PubMed ID: 37129541
[TBL] [Abstract][Full Text] [Related]
6. Human leucocyte antigens and Japanese patients with polymyalgia rheumatica: the protective effect of
Nogi S; Oka S; Higuchi T; Furukawa H; Shimada K; Azuma T; Sugiyama T; Hirano F; Okamoto A; Fujimori M; Horai Y; Ihata A; Hashimoto A; Komiya A; Matsui T; Fukui N; Katayama M; Migita K; Tohma S
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38253597
[TBL] [Abstract][Full Text] [Related]
7. The contributions of deleterious rare alleles in NLRP12 and inflammasome-related genes to polymyalgia rheumatica.
Higuchi T; Oka S; Furukawa H; Tohma S
Sci Rep; 2024 Jan; 14(1):490. PubMed ID: 38177227
[TBL] [Abstract][Full Text] [Related]
8. Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank.
Chatzigeorgiou C; Taylor JC; Elliott F; O'Sullivan EP; Morgan AW; Barrett JH; Mackie SL
Rheumatol Adv Pract; 2023; 7(3):rkad095. PubMed ID: 38033363
[TBL] [Abstract][Full Text] [Related]
9. Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism.
Genre F; Prieto-Peña D; Pulito-Cueto V; Ocejo-Vinyals JG; Atienza-Mateo B; Muñoz Jiménez A; Ortiz-Sanjuán F; Romero-Yuste S; Moriano C; Galíndez-Agirregoikoa E; Calvo I; Ortego Centeno N; Álvarez-Rivas N; Miranda-Filloy JA; Llorente I; Blanco R; Gualillo O; Martín J; Castañeda S; López-Mejías R; Remuzgo-Martínez S; González-Gay MA
Clin Exp Rheumatol; 2023 Apr; 41(4):910-915. PubMed ID: 36912345
[TBL] [Abstract][Full Text] [Related]
10. Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumatica.
Manzo C; Castagna A; Veronese N; Isetta M
Reumatologia; 2023; 61(6):432-438. PubMed ID: 38322103
[TBL] [Abstract][Full Text] [Related]
11. Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey.
Jarrot PA; Mirouse A; Ottaviani S; Cadiou S; Salmon JH; Liozon E; Parreau S; Michaud M; Terrier B; Gavand PE; Trefond L; Lavoiepierre V; Keraen J; Rekassa D; Bouldoires B; Weitten T; Roche D; Poulet A; Charpin C; Grobost V; Hermet M; Pallure M; Wackenheim C; Karkowski L; Grumet P; Rogier T; Belkefi N; Pestre V; Broquet E; Leurs A; Gautier S; Gras V; Gilet P; Holubar J; Sivova N; Schleinitz N; Durand JM; Castel B; Petrier A; Arcani R; Gramont B; Guilpain P; Lepidi H; Weiller PJ; Micallef J; Saadoun D; Kaplanski G
Hum Vaccin Immunother; 2024 Dec; 20(1):2334084. PubMed ID: 38563792
[TBL] [Abstract][Full Text] [Related]
12. Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways.
Veroutis D; Argyropoulou OD; Goules AV; Kambas K; Palamidas DA; Evangelou K; Havaki S; Polyzou A; Valakos D; Xingi E; Karatza E; Boki KA; Cavazza A; Kittas C; Thanos D; Ricordi C; Marvisi C; Muratore F; Galli E; Croci S; Salvarani C; Gorgoulis VG; Tzioufas AG
Ann Rheum Dis; 2024 Feb; 83(3):342-350. PubMed ID: 38050005
[TBL] [Abstract][Full Text] [Related]
13. Treatment Patterns, Disease Burden, and Outcomes in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica: A Real-World, Electronic Health Record-Based Study of Patients in Clinical Practice.
Craig G; Knapp K; Salim B; Mohan SV; Michalska M
Rheumatol Ther; 2021 Mar; 8(1):529-539. PubMed ID: 33638132
[TBL] [Abstract][Full Text] [Related]
14. Association between infection and the onset of giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis.
Pacoureau L; Barde F; Seror R; Nguyen Y
RMD Open; 2023 Nov; 9(4):. PubMed ID: 37949615
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Newly Diagnosed Malignancies in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis, Comparison of 18F-FDG PET/CT Scan with Chest X-ray and Abdominal Ultrasound: Data from a 40 Week Prospective, Exploratory, Single Centre Study.
Emamifar A; Hess S; Ellingsen T; Due Kay S; Christian Bang J; Gerke O; Syrak Hansen P; Ahangarani Farahani Z; Petersen H; Marcussen N; Jensen Hansen IM; Thye Rønn P
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33291857
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Relapse and/or Prolonged Glucocorticoid Therapy in Polymyalgia Rheumatica: Multicenter Study in 185 Patients.
Vinicki JP; Gut O; Maliandi MDR; Velasco Zamora JL; Linarez M; Cusa MA; Got J; Spinetto MA; Estevez AJ; Brigante A; Curti AC; Costi AC; Cavallasca J
J Clin Rheumatol; 2024 Jan; 30(1):e34-e38. PubMed ID: 37185203
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of malignancy in patients with suspected polymyalgia rheumatica or giant cell arteritis, examined with FDG-PET/CT.
Gorlen TF; Brittain JM; Østergaard M; Fischer BM; Døhn UM; Terslev L
Front Med (Lausanne); 2024; 11():1309905. PubMed ID: 38449885
[TBL] [Abstract][Full Text] [Related]
18. Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway.
Prieto-Peña D; Genre F; Pulito-Cueto V; Ocejo-Vinyals JG; Atienza-Mateo B; Muñoz Jiménez A; Ortiz-Sanjuán F; Romero-Yuste S; Moriano C; Galindez-Agirregoikoa E; Calvo I; Ortego Centeno N; Álvarez-Rivas N; Miranda-Filloy JA; Baldivieso-Achá JP; Blanco R; Gualillo O; Martín J; Castañeda S; López-Mejías R; Remuzgo-Martínez S; González-Gay MA
Clin Exp Rheumatol; 2023 Apr; 41(4):864-869. PubMed ID: 36533991
[TBL] [Abstract][Full Text] [Related]
19. Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation.
Mackie SL; Taylor JC; Haroon-Rashid L; Martin S; Dasgupta B; Gough A; Green M; Hordon L; Jarrett S; Pease CT; Barrett JH; Watts R; Morgan AW; ;
Arthritis Res Ther; 2015 Jul; 17(1):195. PubMed ID: 26223536
[TBL] [Abstract][Full Text] [Related]
20. Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica.
Seitz P; Cullmann J; Bucher S; Bütikofer L; Reichenbach S; Lötscher F; Amsler J; Christ L; Bonel HM; Villiger PM; Seitz L
Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38265241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
